Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Akums Drugs And Pharmaceuticals share price/ Akums Drugs And Pharmaceuticals Profit Loss Annual
Akums Drugs And Pharmaceuticals Profit & Loss Annual
Trade672.40 +32.00 (5.00%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 4,178.18 | 3,654.82 | 3,671.89 | 2,722.63 |
| Total Revenue | 4,178.18 | 3,654.82 | 3,671.89 | 2,722.63 |
| Costof Revenue Total | 2,743.02 | 2,454.88 | 2,488.05 | 1,792.26 |
| Gross Profit | 1,435.16 | 1,199.94 | 1,183.84 | 930.37 |
| Selling/ General/ Admin Expenses Total | 894.75 | 836.70 | 728.40 | 590.57 |
| Depreciation/ Amortization | 125.64 | 112.81 | 94.68 | 69.84 |
| Unusual Expense( Income) | 25.17 | 69.75 | 12.98 | 10.00 |
| Other Operating Expenses Total | 59.22 | 63.33 | 48.29 | 47.95 |
| Total Operating Expense | 3,847.81 | 3,537.46 | 3,372.39 | 2,510.62 |
| Operating Income | 330.37 | 117.36 | 299.50 | 212.01 |
| Interest Inc( Exp) Net- Non- Op Total | -3,885.51 | 25.60 | -4,981.08 | -499.40 |
| Gain( Loss)on Saleof Assets | -10.40 | 20.61 | -10.11 | -4.04 |
| Other Net | 13.95 | 28.32 | 6.42 | 10.59 |
| Net Income Before Taxes | -45.28 | 150.30 | -193.20 | 172.26 |
| Provisionfor Income Taxes | -46.07 | 52.48 | 57.68 | 48.83 |
| Net Income After Taxes | 0.79 | 97.82 | -250.87 | 123.44 |
| Minority Interest | -4.83 | -2.96 | -1.66 | -0.73 |
| Net Income Before Extra Items | -4.04 | 94.86 | -252.54 | 122.71 |
| Net Income | -4.04 | 94.86 | -252.54 | 122.71 |
| Income Availableto Com Excl Extra Ord | -4.04 | 94.86 | -252.54 | 122.71 |
| Income Availableto Com Incl Extra Ord | -4.04 | 94.86 | -252.54 | 122.71 |
| Diluted Net Income | -4.04 | 94.86 | -252.54 | 122.71 |
| Diluted Weighted Average Shares | 15.74 | 15.74 | 15.74 | 15.74 |
| Diluted EPS Excluding Extra Ord Items | -0.26 | 6.03 | -16.04 | 7.80 |
| DPS- Common Stock Primary Issue | 0.00 | 0.00 | 0.00 | 0.00 |
| Diluted Normalized EPS | 0.83 | 8.83 | -15.47 | 8.27 |
*All figures in crores except per share values
Akums Drugs And Pharmaceuticals Quick Links
Akums Drugs And Pharmaceuticals Dividend Akums Drugs And Pharmaceuticals Bonus Akums Drugs And Pharmaceuticals News Akums Drugs And Pharmaceuticals AGM Akums Drugs And Pharmaceuticals Rights Akums Drugs And Pharmaceuticals Splits Akums Drugs And Pharmaceuticals Board Meetings Akums Drugs And Pharmaceuticals Key Metrics Akums Drugs And Pharmaceuticals Shareholdings Akums Drugs And Pharmaceuticals Balance Sheet Akums Drugs And Pharmaceuticals Cashflow Akums Drugs And Pharmaceuticals Q1 Results Akums Drugs And Pharmaceuticals Q2 Results Akums Drugs And Pharmaceuticals Q3 Results Akums Drugs And Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)